Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis


YÜCE M., Sert F., Torabfam M., Parlar A., Gurel B., Cakir N., ...Daha Fazla

ANALYTICA CHIMICA ACTA, cilt.1152, 2021 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 1152
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.aca.2020.12.064
  • Dergi Adı: ANALYTICA CHIMICA ACTA

Özet

The similarity between originator and biosimilar monoclonal antibody candidates are rigorously assessed based on primary, secondary, tertiary, quaternary structures, and biological functions. Minor differences in such parameters may alter target-binding, potency, efficacy, or half-life of the molecule. The charge heterogeneity analysis is a prerequisite for all biotherapeutics. Monoclonal antibodies are prone to enzymatic or non-enzymatic structural modifications during or after the production processes, leading to the formation of fragments or aggregates, various glycoforms, oxidized, deamidated, and other degraded residues, reduced Fab region binding activity or altered FcR binding activity. Therefore, the charge variant profiles of the monoclonal antibodies must be regularly and thoroughly evaluated. Comparative structural and functional analysis of physically separated or fractioned charged variants of monoclonal antibodies has gained significant attention in the last few years. The fraction-based charge variant analysis has proved very useful for the biosimilar candidates comprising of unexpected charge isoforms. In this report, the key methods for the physical separation of monoclonal antibody charge variants, structural and functional analyses by liquid chromatographymass spectrometry, and surface plasmon resonance techniques were reviewed.